» Articles » PMID: 33151473

The Novel Target of Colorectal Carcinoma: TRIM44 Regulates Cell Migration and Invasion Via Activation of CXCR4/NF-κB Signaling

Overview
Date 2020 Nov 5
PMID 33151473
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Tripartite motif containing 44 (TRIM44) has been reported to regulate various biological effects in malignant cancers and matrix Metalloproteinases has been demonstrated to be associated with cancer cell migration and invasion. Nonetheless, the expression and molecular mechanism of TRIM44 in colorectal cancer (CRC) remain rarely known. TRIM44 was overexpressed or knocked down in CRC cells. Subsequently, the effects of TRIM44 on cell migration and invasion as well as underlying molecular mechanisms were detected. Data showed that TRIM44 was highly expressed in CRC cell lines. Downregulation of TRIM44 inhibited the cell viability, migration, and invasion in SW-480 cells. In addition, overexpression of TRIM44 enhanced the expression of NF-κB and CXCR4, and enhanced the binding between NF-κB and CXCR4 promoter region. In summarize, TRIM44 may serve as a potential target for CRC diagnosis and progression.

Citing Articles

The role of lidocaine in cancer progression and patient survival.

Chida K, Kanazawa H, Kinoshita H, Roy A, Hakamada K, Takabe K Pharmacol Ther. 2024; 259:108654.

PMID: 38701900 PMC: 11162934. DOI: 10.1016/j.pharmthera.2024.108654.


Unveiling clinical significance and tumor immune landscape of CXCL12 in bladder cancer: Insights from multiple omics analysis.

Tuo Z, Feng D, Jiang Z, Bi L, Yang C, Wang Q Chin J Cancer Res. 2024; 35(6):686-701.

PMID: 38204439 PMC: 10774138. DOI: 10.21147/j.issn.1000-9604.2023.06.12.


TRIM44 promotes BRCA1 functions in HR repair to induce Cisplatin Chemoresistance in Lung Adenocarcinoma by Deubiquitinating FLNA.

Zhang S, Cao M, Yan S, Liu Y, Fan W, Cui Y Int J Biol Sci. 2022; 18(7):2962-2979.

PMID: 35541909 PMC: 9066100. DOI: 10.7150/ijbs.71283.

References
1.
Gomez-Dominguez E, Trapero-Marugan M, del Pozo A, Cantero J, Gisbert J, Mate J . The colorectal carcinoma prognosis factors. Significance of diagnosis delay. Rev Esp Enferm Dig. 2006; 98(5):322-9. DOI: 10.4321/s1130-01082006000500002. View